Nuva Ring Essay

Published: 2020-04-22 08:25:56
1303 words
5 pages
printer Print
essay essay

Category: Birth control

Type of paper: Essay

This essay has been submitted by a student. This is not an example of the work written by our professional essay writers.

Hey! We can write a custom essay for you.

All possible types of assignments. Written by academics

GET MY ESSAY
In the 1950s there was immensely uncomfortable and inappropriate for people to touch the genital area. The vaginal ring, NuvaRing would undoubtedly be rejected in those days of modesty and morals. Fortunately for the founders of the new alternative to oral contraceptives, the people of the late 20th and early 21st century have a completely different attitude towards the body and contraception. In 2002 the most popular form of contraception amongst unmarried people was the Pill and the male condom (http://www. aippg. et/forum/viewtopic. php? t=162574).

Judging from the fact that one of those requires a hefty amount of genital manipulation, we can conclude that ultimately people have let go of their stipules and are not as apprehensive about exploring their bodies. Thus, with this new general mindset, NuvaRing was brought to the American and European public. NuvaRing was developed by the pharmaceutical company Organon. Organon submitted the drug for FDA approval in December of 1999 but it was not approved until October of 2001.

Some of the reasons for the delay in approval were that FDA chemists wanted Organon to do clinical studies to see if antimycotic medicines or tampon use affected the efficacy of NuvaRing. Ultimately they found out that the only effect that either of the two had was the Toxic Shock Syndrome possibility that was caused by tampons, diaphragms and other barrier methods. Also, Organon wanted to alter the wording of the package insert proposed by the FDA and they also made some changes to the outside packaging. The Netherlands were the first country to approve NuvaRing in February of 2001 and by June, 14 other European countries approved it.

Today, NuvaRing is available by a doctors prescription in 32 countries and is used by more than 1. 5 million women (http://en. wikipedia. org/wiki/NuvaRing). However, in 2007, the 12. 5 billion dollar company Schering-Plough bought out Organon Biosciences, so now Nuvaring is being sold by the same pharmaceutical giant that sells Claritin, Nasonex, and even animal medicines. NuvaRings package insert says that it is a non-biodegradable, flexible, transparent, colorless to almost colorless, combination contraceptive vaginal ring containing two active components, a progestin, etonogestrel, and an estrogen, ethinyl estradiol.

This two inch ring is supposed to be inserted into the vagina by the patients fingers and once inserted; the ring releases the hormones over a three week period. Like the pill, the primary effect of NuvaRing is to prevent ovulation, but it also causes changes in cervical mucus (which increase the difficulty of sperm entry into the uterus) and the endometrium (which reduce the likelihood of implantation) (from package insert). After three weeks in the vagina, the ring is removed, again by the patients fingers, and the patient is supposed to have a seven day break from the hormones.

About two days after the ring is removed, the patient will experience withdrawal bleeding. It is interesting that although the words withdrawal bleeding are used in the packaging of this device, most women still think that the bleeding is due to their menstrual cycle. So, seven days after the ring is removed, regardless if the bleeding has stopped or not, a new ring must be inserted for the process to start over again. A major benefit of NuvaRing is that there is less room for human error because it only has to be inserted once a month.

Thus, it provides the answer for population control advocates who believe women do not have the mental capacities to adhere to the pill. Generally, most of the advertisements and research done on NuvaRing compare and contrast it to the oral contraceptive. Thom Dieber, an employee of Organon writes that a recent study of womens wishes in relation to contraceptive methods showed that most American women would prefer a contraceptive that requires monthly, not daily, administration (Dieber, 2002); thus showing that women were tired of the monotony and hassle of taking the pill every day.

In a TV commercial for NuvaRing, there are women arranged in the circular form of Pill dispensers and the women sing Monday, Tuesday, Wednesday, Thursday, Friday, Saturday, Sunday, everyday! Then the narrator urges people to break free from the pack and the song Goodbye to you comes on. From earlier research on oral contraceptives, we know that propaganda has a huge effect on the American public so pharmaceutical companies know that the media is their best bet for getting people to abolish their slavery to the Pill. This TV commercial empowers women and makes them feel like they are fighters who gain freedom from their oppressors.

It is ironic that women are told that they should say goodbye to the pill yet the people who invented NuvaRing probably regard these women as incapable of following the strict Pill regimen. Some of the nuisances that NuvaRing causes are that sometimes it slips out when you are having a bowel movement, during intercourse, or while taking out a tampon. As long as the ring is reinserted before three hours, there is no damage done to the contraceptive effects. Most women rarely ever feel the ring when it is inside of them; a high percentage of male partners have felt the ring during intercourse but they do not seem to mind.

If a woman wants to remove the ring before intercourse she can as long as it is reinserted within three hours. Some side-effects of NuvaRing are similar to those of the pill such as nausea, vomiting, breast tenderness, and depression. In a study done by Veres, Miller, and Burington that compared these two forms of contraception, they found that breakthrough bleeding, or spotting, was more frequent amongst pill users while the most common side-effect for NuvaRing users was vaginal wetness and or the presence of yeast.

This team of researchers as well as Dieben and other workers of Organon also studied weight-gain amongst NuvaRing users and they all conclude that NuvaRing did not have a significant effect on weight but weight-gain is still listed on the package insert as one of the potential side-effects. A major side-effect of NuvaRing is the risk of blood clots, especially in the leg, pulmonary embolisms, thrombosis, and strokes. This year (2008), many groups of people are urging the FDA to recall this device because NuvaRing may result in amputation, permanent organ damage, extensive rehabilitation, surgeries, and in some cases even death.

Side effects are damaging, painful, and in the most severe cases they become permanent (http://www. nuvaringsideeffectslawyer. com/nuva-ring-lawsuits. html. ). A group of lawyers are offering legal aid to those who suffered with NuvaRing. The lawyers seek to gain financial compensation for victims medical bills, loss of a loved one, or overall suffering due to NuvaRing. These lawyers even have a TV commercial very reminiscent to the ones that gathered up ephedra victims. This can open a can of worms because some people looking to atch a quick financial break can lie and jump on the lawyers bandwagon; if NuvaRing is banned we can lose the contraceptive that has come very close to being a running-mate with the Pill. Organons NuvaRing, although young in age, has made its mark in the contraceptive world. Its pros and cons have been intertwined profusely with those of the oral contraceptive because their methods of inhibiting pregnancy are very similar. The landmark difference between these two is the amount of patient input.

As Dieben states, Good compliance with a contraceptive method is essential to maintain contraceptive reliability (Dieben, 2002). Since the compliance of women is not as trustworthy as doctors might like, this monthly method seems like a happy medium between the daily inputs required from Pill users and the once every three months of the Depo-Provera shot. Nonetheless, it is still a major problem that most of the endocrinological contraceptive methods put at risk the lives of otherwise healthy women.

Warning! This essay is not original. Get 100% unique essay within 45 seconds!

GET UNIQUE ESSAY

We can write your paper just for 11.99$

i want to copy...

This essay has been submitted by a student and contain not unique content

People also read